Back to results
US 6,306,640 B1Granted
Melanoma antigenic peptides
AssigneeGenzyme Corporation
InventorCharles A. Nicolette
Life of this patent
Estimating the term…
Abstract
Thus, this invention provides novel, synthetic polypeptide vaccines against human melanoma and methods for making these vaccines. Polynucleotides encoding these polypeptides are further provided herein. These compositions are useful as melanoma caccinies and in adoptive immunotherapy.
Claims10
A peptide consisting of the sequence FLDQVAFXV (Seq. ID No. 1), wherein X is any amino acid.
A peptide consisting of the sequence FLFSWYAXV (Seq. ID No. 3), wherein X is any amino acid.
Dependencies are inferred from the claim text.